Back

Derivation and validation of the incremental prognostic value of increased triglyceride glucose index

30 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (4) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Stavros Athanasopoulos

(Greece)

6 More presentations in this session

Presentation thumbnail
Polygenic prediction of cardiorespiratory fitness and relation to cardiovascular disease: the HUNT study
Miss M. Klevjer (Trondheim, NO)
Abstract Slides Video
Presentation thumbnail
A blood-based biomarker score for monitoring secondary prevention in coronary artery disease
Doctor B. Schmitz (Ennepetal, DE)
Abstract Slides Video
Presentation thumbnail
Coronary calcium score may better discriminate against high-risk subjects with little conventional cardiovascular risk factors
Doctor G. Bettencourt Abreu (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
The association between computed tomography-derived epicardial adipose tissue volume and major adverse cardiovascular events: a systematic review and meta-analysis
Ms E. Aldous (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Inflammation and LDL cholesterol contribute independently to the progression of early human atherosclerotic plaque
Doctor G. Mendieta Badimon (Barcelona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors (4)

The Event

Event poster

ESC Congress 2025

30 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Associations between an insulin resistance guide, the triglyceride glucose index (TyG) and subclinical atherosclerosis progression in a coronary population
thumbnail
Congress Presentation
The association of triglyceride-glucose index with coronary artery disease in patients who underwent coronary angiogram at a private tertiary hospital : a cross-sectional study
thumbnail
Congress Presentation
Associations of TyG Index and TyG-obesity-related parameters to cardiovascular disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources